OneDrug is a pioneering medical technology startup focused on advancing precision medicine for better patient outcomes. It empowers healthcare providers with smart point-of-care technologies to personalize patient treatment.

OneDrug

Almac Group provides services across the drug development lifecycle, including pharmaceutical development, diagnostics, and clinical services. The company supports global pharma and biotech firms with tailored solutions.

Almac Group

Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates through four segments: Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. The Biologics segment provides biologic cell-line; develops and manufactures cell therapy and viral based gene therapy; formulation, development, and manufacturing for parenteral dose forms, including vials, prefilled syringes, vials, and cartridges; and analytical development and testing services. The Oral and Specialty Delivery segment offers formulation, development, and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. This segment also offers oral delivery solutions platform comprising pre-clinical screening, formulation, analytical development, and current good manufacturing practices services. The Clinical Supply Services segment offers manufacturing, packaging, storage, distribution, and inventory management for drugs and biologics clinical trials. It also offers FastChain demand-led clinical supply services. The company serves pharmaceutical, biotechnology, and consumer health companies; and companies in other healthcare market segments, such as animal health and medical devices, as well as in cosmetics industries. Catalent, Inc. was incorporated in 2007 and is headquartered in Somerset, New Jersey.

Catalent, Inc.

Healthians provides health checkups, blood tests, scans, and doctor consultations as part of its medical services. The company operates in various cities and offers packages for full body checkups and specialized health tests.

Metric
Company Name	OneDrug	Almac Group	Catalent, Inc.	Healthians
Symbol			CTLT
MSH ID	CO:ONEDRUG	COM:ALMACGROUP	COM:CATALENT	COM:HEALTHIANS
Market	PRIVATE	PRIVATE	STOCKS	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare	Healthcare & Health Services
Industry	Medical Devices	Pharmaceuticals	Drug Manufacturers - Specialty & Generic	Healthcare
Country	US	GB	US	IN
Stage
Employee Count			18K
Website	onedrug.co	almacgroup.com	catalent.com	healthians.com
LinkedIn
Founders

Metric
Market Cap			10.39B
Enterprise Value
Monthly Web Traffic			215.31K
Web Traffic Growth			0.22
Valuation
Raised Capital

Metric
Revenue			4.38B
Revenue (LTM)
Revenue (NTM)
Gross Profit			953M
EBITDA			634M
Operating Income			145M
Net Income			-1.04B
EPS			-5.76
Diluted EPS			-5.76
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin			0.22
Operating Profit Margin			-0.14
EBITDA Margin			0.14
Net Profit Margin			-0.23
Return on Equity			-0.27
Return on Assets			-0.10
Return on Capital Employed			-0.07

CO:ONEDRUG

OneDrug

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio			-11.39
P/B Ratio			2.76
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio			2.61
EV Multiple			88.01

Metric
Days Sales Outstanding			71.17
Days Payables Outstanding			41.18
Days Inventory Outstanding			84.59
Operating Cycle			208.07
Cash Conversion Cycle			166.77
Asset Turnover			0.45

Metric
Operating Cash Flow			268M
Free Cash Flow			268M
Cash Flow to Debt			0.06
Operating Cash Flow/Sales			0.06
Free Cash Flow Yield			-0.02

Metric
Cash & Equivalents			289M
Accounts Receivable
Inventory			574M
Goodwill
Debt to Capitalization			0.58
Debt to Assets			0.49
Current Ratio			1.71
Quick Ratio			1.96

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue			0.01
R&D to Revenue
SG&A to Revenue